A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sekeres, MA; Othus, M; List, AF; Odenike, O; Stone, RM; Gore, SD; Litzow, MR; Buckstein, R; Velasco, MR; Gaur, R; Atallah, E; Attar, E; Appelbaum, FR; Erba, HP

Published Date

  • December 6, 2014

Published In

Volume / Issue

  • 124 / 21

Published By

Pages

  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971